Can a Preoperative CA 125 Level Be a Criterion for Full Pelvic Lymphadenectomy in Surgical Staging of Endometrial Cancer?
- 1 July 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 86 (1) , 28-33
- https://doi.org/10.1006/gyno.2002.6664
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancerJournal of Surgical Oncology, 2001
- Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without TeletherapyGynecologic Oncology, 2001
- Preoperative CA 125 in endometrial cancer: Is it useful?American Journal of Obstetrics and Gynecology, 2000
- Value of Preoperative CA 125 Level in the Management of Uterine Cancer and Prediction of Clinical OutcomePublished by Wolters Kluwer Health ,1998
- Staging Laparotomy for Endometrial Carcinoma: Assessment of Retroperitoneal Lymph NodesGynecologic Oncology, 1995
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Evaluation of unfavorable histologic subtypes in endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the uterine corpusGynecologic Oncology, 1982